Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • gladpick gladpick Nov 13, 2012 6:02 PM Flag

    IT IS JUST AMAZING

    HOW STUPID SOME OF THESE ANALYSTS ARE.

    Here is what one of them said:

    "Gilead will likely be the first to market with a simple and efficacious one pill, once-daily regimen,” Michael Yee, an RBC Capital Markets analyst in San Francisco, said in a note."

    ONE pill? If the idiot analyst read the GILD report it had THREE different drugs and not one pill. And these people get paid for the crap they spew?.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • [Over the weekend Gilead presented results from its combination of sofosbuvir and daclatasvir that cured between 98 and 100 percent of patients within 12 weeks.]

      Are they assuming that DACLATASVIR belongs to GILEAD? Did Gilead buy Bristol-Myers too?
      The trial for 7977+BMS790052(=Daclatasvir) had 3 arms, and all 3 arms dosed the dual or triple (the 3rd was Riba) combos that lasted 24 weeks, not 12weeks! Where do they get the news?

      Gilead is now developing 7977+5885, and decided not to develop 7977+Daclatasvir combo.

    • and they get paid very well. no brains, but paid well. it's all a game and they control it. you just have to be lucky to be on the right side of the trade.

 
VRTX
121.25+0.91(+0.76%)Mar 30 4:00 PMEDT